News

“Trasylol has been proven safe and effective in reducing blood loss and transfusion requirements in coronary artery bypass surgery, and we are studying the drug to determine if

The transaction is part of GSK’s strategic initiative to expand its vaccine research and production network in North America, and adds to the company’s recent acquisitions of Corixa

The agreement provides for Gene Logic to receive success-based milestone payments for each drug candidate Roche returns to clinical development. In addition, Gene Logic will receive royalties for

AstraZeneca will make an initial payment of GBP16.3 million and will make a GBP7.5 million equity investment in Protherics to be paid in cash. Protherics will receive additional

The company’s will initially use Ambrx’ proprietary technology platform to generate novel pegylated interferon alpha molecules. Under the terms of the agreement, Roche will fund R&D of the

K252a is a research compound being evaluated by the company’s for its potential to topically treat psoriasis, and for potential use in the prevention and treatment of restenosis.

New River said that the application had been completed on schedule and that it anticipates approval and subsequent launch for the drug in 2006. In addition, the company

Depakote extended release tablets offers patients the convenience of taking this medication once a day. When taken once-a-day, the extended release formulation of the drug helps provide more

The compound is presently in phase I development for the treatment of acute heart failure, and data emerging from this trial has encouraged the company to initiate development